|
NIP7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.201400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.801000E-01 |
| Normal-vs-Stage2 |
8.182200E-01 |
| Normal-vs-Stage3 |
8.233600E-01 |
| Normal-vs-Stage4 |
3.321200E-01 |
| Stage1-vs-Stage2 |
5.982000E-01 |
| Stage1-vs-Stage3 |
9.904000E-01 |
| Stage1-vs-Stage4 |
3.403600E-01 |
| Stage2-vs-Stage3 |
6.697000E-01 |
| Stage2-vs-Stage4 |
2.875600E-01 |
| Stage3-vs-Stage4 |
4.338800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.004000E-01 |
| Normal-vs-AfricanAmerican |
7.537200E-01 |
| Normal-vs-Asian |
7.759400E-01 |
| Caucasian-vs-AfricanAmerican |
4.704000E-01 |
| Caucasian-vs-Asian |
8.981800E-01 |
| AfricanAmerican-vs-Asian |
7.071400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.626800E-01 |
| Normal-vs-Female |
2.144000E-01 |
| Male-vs-Female |
3.650200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.294400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.106600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.272400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.595400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.312000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.385800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.884200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.507200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.435400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.677000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.099000E-01 |
| Normal-vs-Grade 2 |
4.883400E-01 |
| Normal-vs-Grade 3 |
9.750000E-01 |
| Normal-vs-Grade 4 |
7.162400E-01 |
| Grade 1-vs-Grade 2 |
8.600200E-01 |
| Grade 1-vs-Grade 3 |
8.878600E-01 |
| Grade 1-vs-Grade 4 |
9.657200E-01 |
| Grade 2-vs-Grade 3 |
3.510400E-01 |
| Grade 2-vs-Grade 4 |
7.776200E-01 |
| Grade 3-vs-Grade 4 |
6.910800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.580790E-01 |
| Normal-vs-ccB subtype |
7.960800E-01 |
| ccA subtype-vs-ccB subtype |
3.327800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.875800E-01 |
| Normal-vs-N1 |
3.449000E-01 |
| N0-vs-N1 |
4.967200E-01 |
|
|
